Marissa Shapiro
-
Sean Davies awarded Scaling Success grant to develop small molecules with promise of protecting against cardiometabolic disease
Davies received a Scaling Success grant to advance research on NAPE-PLD activators—potential key players in fighting cardiometabolic diseases. The team’s innovative research could lead to breakthrough treatments. Read MoreMar. 28, 2024
-
Teams to create one-stop resource for human pancreatic data to foster diabetes research
Leading investigators in diabetes, pancreas and islet biology, and computational biology have received $12.5 million in two five-year awards from the National Institutes of Health to create the world’s first, integrated knowledge base of human-derived tissue- and cellular-level pancreatic information to support innovative, collaborative and reproducible research. Read MoreMar. 28, 2024
-
Vanderbilt biochemists contribute to breakthrough discovery of first new antibacterial class in decades
Led by Neil Osheroff, Vanderbilt researchers are the first to undertake a systematic analysis of the mechanism of action of geoptidacin. Gepotidacin is poised to become the first new class of antibacterials to be approved for use in humans in decades. Read MoreMar. 26, 2024
-
Jay Jerome honored by Microscopy Society of America
Jerome is the 2024 recipient of the Distinguished Scientist Award, which honors “preeminent senior scientists for a long-standing record of achievement in the field of microscopy and microanalysis.” Read MoreMar. 26, 2024
-
Calipari launches AUD Research and Education Center with prestigious $8.9 million NIH grant
An $8.9 million grant from the NIH will establish the Vanderbilt AUD Research and Education Center, enhancing Vanderbilt University’s national leadership in neuroscience and addiction research. This initiative aims to foster interdisciplinary collaboration, advance understanding and treatment of alcohol use disorder, and engage the public through education and outreach efforts. Read MoreMar. 21, 2024
-
Vanderbilt basic scientists receive National Science Foundation grant to explore RNA behavior
Manuel Ascano and Alissa Weaver are one of nine research teams to receive funding to understand the potential biotechnological uses of RNA more fully. The research is expected to provide opportunities to partner with industry to translate knowledge gained in the laboratory into marketable new therapeutics. Read MoreMar. 18, 2024
-
Lab-to-Table Conversation March 26 is ‘Biotech Entrepreneurship: Stories & Strategies’
Join the next Lab-to-Table conversation, “Biotech Entrepreneurship: Stories & Strategies” on March 26 at 11 a.m. CT. Read MoreMar. 12, 2024
-
Outstanding faculty in the Basic Sciences recognized for high-impact work
A pillar of this community is the female faculty who are passionate about advancing and making notable impacts on their basic sciences fields. For many, their efforts have been recognized by the highest-caliber professional societies around the world. Read MoreMar. 7, 2024
-
The lasting impact of Vanderbilt’s life sciences Nobelists
As one of the top 50 U.S. universities with the most Nobel Prize winners, Vanderbilt stands as a cornerstone of scientific achievement and ground-breaking research. Read MoreMar. 7, 2024
-
DNA is the ultimate blueprint— but epigenetics changes how it’s read
William Tansey, professor of cell and developmental biology and biochemistry and co-leader of the Vanderbilt-Ingram Cancer Center Genome Maintenance Program, gives us a bird’s-eye view of epigenetics and some of Vanderbilt’s research contributions to the space. Read MoreMar. 7, 2024